Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma
Bruna Calsina(Spanish National Cancer Research Centre), Juan F. Garcı́a(MD Anderson Cancer Center Madrid), Luis J. Leandro‐García(Spanish National Cancer Research Centre), María Currás-Freixes(Spanish National Cancer Research Centre), Margo Dona(Radboud University Nijmegen), Coral Fustero‐Torre(Spanish National Cancer Research Centre), Giovanna Roncador(Spanish National Cancer Research Centre), Eduardo Gil(Spanish National Centre for Cardiovascular Research), Ángel Fernández-Sanromán(The Francis Crick Institute), Felix Beuschlein(University of Zurich), Bárbara Hernando(Universitat Jaume I), Martin Faßnacht(University of Würzburg), Scherezade Jiménez(Spanish National Cancer Research Centre), Marta Pulgarín-Alfaro(Spanish National Cancer Research Centre), Cristina Rodríguez‐Antona(Instituto de Salud Carlos III), Javier Lanillos(Spanish National Cancer Research Centre), Adrià López‐Fernández(Vall d'Hebron Hospital Universitari), Rafael Torres‐Pérez(Spanish National Cancer Research Centre), Massimo Mannelli(University of Florence), Ángeles Rubio(Spanish National Cancer Research Centre), Rodrigo A. Toledo(Instituto de Salud Carlos III), Sara Mellid(Spanish National Cancer Research Centre), Javier Aller(Hospital Universitario Puerta de Hierro Majadahonda), Graeme Eisenhofer(University Hospital Carl Gustav Carus), Sonsoles Guadalix(Research Institute Hospital 12 de Octubre), Henri Timmers(Radboud University Nijmegen), Nicole Bechmann(University Hospital Carl Gustav Carus), Juan María Roldán‐Romero(European Bioinformatics Institute), Rita María Regojo(Hospital Universitario La Paz), Elena Piñeiro-Yáñez(Spanish National Cancer Research Centre), Cristina Álvarez‐Escolá(Hospital Universitario La Paz), María Isabel Del Olmo-García(Hospital Universitari i Politècnic La Fe), María Monteagudo(Spanish National Cancer Research Centre), Sandra Rodríguez(Spanish National Cancer Research Centre), Alberto Díaz‐Talavera(Centro de Biología Molecular Severo Ochoa), Santiago García‐Martín(Spanish National Cancer Research Centre), María Santos(Spanish National Cancer Research Centre), Stephanie Fliedner(University Hospital Schleswig-Holstein), Cristina Montero‐Conde(Spanish National Cancer Research Centre), Marcus Quinkler(Charité - Universitätsmedizin Berlin), María Calatayud(Hospital Universitario 12 De Octubre), Alberto Cascón(Spanish National Cancer Research Centre), Elena Rapizzi(El.En. Group (Italy)), Orlando Domı́nguez(Spanish National Cancer Research Centre), Geoffrey Macintyre(Spanish National Cancer Research Centre), Patricia González(Neuron BioPharma (Spain)), Maria Carmen Martín(Spanish National Cancer Research Centre), Rocío Letón, Ángel M. Martínez‐Montes(Spanish National Cancer Research Centre), Eduardo Caleiras(Spanish National Cancer Research Centre)
Cited by 99
Related Papers
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
|European Journal of Endocrinology|2016|1.5k
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors
|European Journal of Endocrinology|2018|927
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
|New England Journal of Medicine|2012|863
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
|Cancer Cell|2017|791